8-K current report · filed Oct 15, 2026

Indivior Pharmaceuticals, Inc. (INDV) 8-K Current Report: October 15, 2026

Item 5.07INDV overview

Short answer

Indivior Pharmaceuticals, Inc. (INDV) filed an 8-K current report with the SEC on October 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved Indivior share issuance for the merger, clearing the Nasdaq Rule 5635 approval requirement.

Indivior Pharmaceuticals, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • Stockholders approved Indivior share issuance for the merger, clearing the Nasdaq Rule 5635 approval requirement
  • 85,455,705 votes for versus 5,563,744 against, with 186,733 abstentions
  • 91,206,182 shares represented, equal to 77.27% of 118,031,934 outstanding shares, establishing a quorum
  • Merger execution can proceed past the shareholder approval milestone, subject to remaining closing conditions

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Indivior Pharmaceuticals, Inc. 8-K filings

Get the next INDV 8-K as it lands

Follow INDV for push alerts, or ask the research agent what this filing means.